Piershale Financial Group, Inc. Tekla Life Sciences Investors Transaction History
Piershale Financial Group, Inc.
- $157 Million
- Q2 2023
A detailed history of Piershale Financial Group, Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Piershale Financial Group, Inc. holds 839 shares of HQL stock, worth $12,417. This represents 0.01% of its overall portfolio holdings.
Number of Shares
839
Previous 820
2.32%
Holding current value
$12,417
Previous $11,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding HQL
# of Institutions
76Shares Held
9.04MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$50.8 Million0.82% of portfolio
-
Morgan Stanley New York, NY490KShares$7.25 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA419KShares$6.21 Million0.53% of portfolio
-
Karpus Management, Inc. Pittsford, NY404KShares$5.98 Million0.18% of portfolio
-
Allspring Global Investments Holdings, LLC347KShares$5.13 Million0.01% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...